Rick brings a wealth of knowledge in medtech innovation and commercialization. His leadership has guided numerous startups through the complexities of developing and launching medical technologies, ensuring their long-term success.

With a multidisciplinary background in technology and healthcare, Andrew combines technical expertise with strategic insight. His commitment to innovation and excellence drives MedTech Angels’ mission to support game-changing startups.

Travis is a visionary entrepreneur and investor whose expertise spans domestic and international markets encompassing strategy, operations, and early-stage growth. He is passionate about empowering startups to scale successfully and create meaningful change in healthcare.

With extensive experience in healthcare operations and investment, Robert has been instrumental in fostering innovative solutions that address critical challenges in the medical industry. His strategic mindset and commitment to impactful investments are at the core of MedTech Angels’ success.

Kate Pietrovito brings deep expertise in clinical evidence strategy and execution, helping de-risk medical innovation and accelerate regulatory readiness, reimbursement, and market adoption.

Jordan Chase brings deep expertise in building and scaling high-performing commercial teams for early-stage medical device companies, accelerating go-to-market execution and reducing talent-related commercialization risk.

Jeremy Kim, MD brings deep clinical and trial-level expertise in interventional radiology and embolization therapies, helping evaluate procedural adoption, clinical differentiation, and real-world execution risk for minimally invasive medical technologies.

Tyler Wanke, MD, MBA brings a rare operator-investor perspective in medical technology, leveraging hands-on company building, board leadership, and clinical training to evaluate technical risk, capital efficiency, and commercialization potential.

David Doster brings decades of commercial leadership experience in medical technology, helping companies execute go-to-market strategy, navigate growth inflection points, and drive sustained revenue and enterprise value creation.

Gaurav Gadodia, MD, is a board certified vascular and interventional radiologist at VIR Chicago and Director of Medical Affairs at MediView XR, bringing a strong background in biomedical engineering and clinical innovation to advance minimally invasive, image guided therapies.

Danielle Bradbury brings deep operator experience across clinical, commercial, and education functions, helping early-stage medical technology companies scale adoption, optimize clinical execution, and drive durable post-sale performance.

Craig Scherer brings decades of medical device product development and accelerator experience, helping early-stage MedTech companies advance technical viability, attract capital, and connect with clinical and strategic partners.

Tony Arnold brings more than two decades of executive leadership in building and scaling venture-backed medical device companies, with deep expertise in capital formation, board governance, and commercialization of complex technologies.

Bruce McNulty, MD brings decades of physician executive and health system leadership experience, offering deep insight into hospital operations, clinical quality, physician alignment, and enterprise decision-making within complex healthcare organizations.

Kelleny Berchuck, PhD brings deep expertise in venture creation and scaling, having built and commercialized tech-enabled healthcare platforms that drive revenue growth, operational efficiency, and expanded patient access across global markets.

Nate Porter brings deep C-suite and private equity–backed operating experience in commercial transformation, M&A, and value creation, helping scale medical technology businesses from growth through successful exit.

Allen is the President and CEO of Stimdia Medical, leading a clinical stage respiratory neuromodulation platform, and brings over two decades of neuromodulation leadership experience including senior commercial roles at Nalu Medical and Boston Scientific.

Carson Dillashaw brings an entrepreneurial, asset-focused perspective to MedTech investing, applying disciplined business operations, risk management, and long-term value thinking to medical innovation and device development.

Joe McClung brings deep expertise in MedTech executive recruiting and commercial leadership, helping early-stage and growth-stage medical device companies build high-impact teams that accelerate commercialization and scale.

Billy C. McCarroll brings more than two decades of operating and infrastructure experience across the U.S. and Southeast Asia, providing a disciplined, execution-focused perspective on scaling complex businesses, capital deployment, and operational risk.

Scott Peairs is a seasoned medical technology commercial leader and advisor with extensive experience driving sales, marketing, and business development for diagnostic and interventional imaging technologies, helping early-stage companies advance commercial traction and strategic partnerships.

Emily Hornak brings decades of leadership in healthcare philanthropy and strategic partnerships, helping align capital, corporate engagement, and hospital priorities to drive scalable impact across pediatric care networks.

Matthew P. Rupert, MD, MS brings a unique physician-engineer perspective, with deep expertise in spine, pain, and implantable technologies, helping evaluate clinical utility, device design, and real-world adoption of minimally invasive therapies.

Isaac Callais brings an entrepreneurial and consumer-driven perspective, with experience building and scaling businesses, applying disciplined execution and market insight to emerging opportunities in MedTech.

Michael Cetta, MD brings a physician-operator and founder perspective, combining decades of clinical leadership with experience scaling healthcare organizations and building medical device companies focused on improving care delivery and efficiency.

Matthew Hightower brings expertise in capital allocation, financial strategy, and risk management, helping evaluate investment opportunities through the lens of structure, incentives, tax efficiency, and long-term value creation.

Thomas E. Serena, MD, FACS brings world-renowned expertise in wound healing, clinical research, and real-world evidence generation, with leadership experience spanning more than 200 clinical trials, global research operations, and medical device innovation.

John Griffin brings deep commercial and strategic leadership experience in image guided and robotic technologies, helping medical device companies accelerate product adoption, global commercialization, and enterprise growth.

Robert Provenzano, MD brings decades of leadership in nephrology, physician practice management, and healthcare operations, helping evaluate reimbursement dynamics, care delivery models, and strategic growth opportunities across complex healthcare environments.

Josh Jackson brings extensive experience across medical and surgical device commercialization, board governance, and end-to-end product development, helping identify strategic growth opportunities and drive long-term value creation in MedTech.

Jay Kendall brings more than two decades of MedTech commercial leadership experience, helping scale orthopedic and surgical businesses through strategic commercialization, product launches, provider education, and accelerated growth execution.

Justin Callais, PhD brings expertise in economics, capital markets, and investment strategy, applying data-driven analysis and long-term market perspectives to early-stage investing and venture evaluation.